EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$243.6bn
Equities Assets Under Management

vd-icon_People_3_Group v3

148
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

19
Average Years’ Financial
Industry Experience

As at 30 June 2025

<span class="notranslate">no data</span>

$243.6bn
Equities Assets Under Management

148
Equities Investment
Professionals

19
Average Years’ Financial
Industry Experience

As at 30 June 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Biotechnology Innovation

A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team

Insights

Productivity lift: A supportive backdrop for earnings growth

How corporate efficiency is supporting profitability and earnings growth.

Chart to Watch: All eyes on homebuilder inventory shift

How falling construction starts could pave the way for inventory relief and market stabilization.

Quick View: NVIDIA looks set for its next growth chapter

NVIDIA is reaffirming its dominant position in the AI infrastructure space.